Mezzanine Management sells Optimapharm to Rohatyn Group
Mezzanine Management has sold Croatian contract research organisation Optimapharm to asset management firm The Rohatyn Group (TRG).
More on CEE
Agilitas 2020 Private Equity closes on €565m
Fund focuses on mid-market companies across western Europe, within a range of sectors
Majority of LPs happy to commit without in-person meeting – survey
Cebile Capital survey finds that 51% of respondents expect to increase PE commitments in 2021
Quantifying PE's appetite for recurring revenue models
Buyouts in sectors where recurring revenue models are predominant went from 8% of European volume in 2010 to 22% in 2021 to date
Iron Wolf Capital eyes €30m-plus fund launch after 2023
Baltic venture capital investor raised €21m for its first fund in 2019
Latest News
Bid Equity's Myneva bolts on Patronis, TTS
Social care and healthcare software platform is following a buy-and-build strategy
Palatine backs Anthesis
Company intends to further boost its growth both organically and via strategic acquisitions
Agilitas 2020 Private Equity closes on €565m
Fund focuses on mid-market companies across western Europe, within a range of sectors
Apax sells Sandaya to InfraVia
Sale ends a five-year holding period for Apax, which acquired a majority stake in Sandaya from Pragma Capital